Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 44,806 | 26,371 | 8,539 | -43,193 | -34,305 |
| Depreciation Amortization | 1,087 | 703 | 345 | 1,695 | 1,295 |
| Income taxes - deferred | 9,864 | 5,637 | 2,993 | 8,132 | 11,295 |
| Accounts receivable | -10,018 | 9,814 | 1,659 | -20,458 | -3,622 |
| Accounts payable and accrued liabilities | 4,264 | 6,992 | 62 | -6,306 | -22 |
| Other Working Capital | -1,084 | -67 | 1,599 | 24,809 | 4,272 |
| Other Operating Activity | 35,172 | 964 | 7,127 | 61,010 | 28,006 |
| Operating Cash Flow | $84,091 | $50,414 | $22,324 | $25,689 | $6,919 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -117,244 | -55,160 | -51,442 | 37,924 | -27,562 |
| PPE Investments | -935 | -264 | -99 | -252 | -59 |
| Investing Cash Flow | $-118,179 | $-55,424 | $-51,541 | $37,672 | $-27,621 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32,177 | 15,925 | 3,180 | 17,250 | 14,530 |
| Other Financing Activity | -6,812 | -2,459 | -412 | -4,984 | -4,406 |
| Financing Cash Flow | $25,365 | $13,466 | $2,768 | $12,266 | $10,124 |
| Beginning Cash Position | 183,581 | 183,581 | 183,581 | 107,954 | 107,954 |
| End Cash Position | 174,858 | 192,037 | 157,132 | 183,581 | 97,376 |
| Net Cash Flow | $-8,723 | $8,456 | $-26,449 | $75,627 | $-10,578 |
| Free Cash Flow | |||||
| Operating Cash Flow | 84,091 | 50,414 | 22,324 | 25,689 | 6,919 |
| Capital Expenditure | -935 | -264 | -99 | -277 | -84 |
| Free Cash Flow | 83,156 | 50,150 | 22,225 | 25,412 | 6,835 |